A previous study on glioblastoma showed that knockdown of MerTK disrupted the rounded morphology of glioma cells with a decrease in tumor stem cell markers, such as Sox2 and Nestin, indicating that MerTK could maintain cells in an undifferentiated state.29 The gene discussed is MERTK; the disease is central nervous system cancer.